ATEC - Alphatec Holdings, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Carlsbad,
United States
Type: Equity
ATEC price evolution
ATEC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $80.98 | $99.83 | $144.09 | $220.97 |
| Short term investments | ||||
| Net receivables | $83.66 | $83.98 | $88.65 | $72.61 |
| Inventory | $183.11 | $172.31 | $152.98 | $136.84 |
| Total current assets | $362.43 | $376.61 | $405.29 | $451.09 |
| Long term investments | ||||
| Property, plant & equipment | $208.44 | $217.79 | $194.76 | $176.25 |
| Goodwill & intangible assets | $171.16 | $172.06 | $175.45 | |
| Total noncurrent assets | $391.98 | $369.29 | $354.12 | |
| Total investments | ||||
| Total assets | $745.89 | $768.59 | $774.58 | $805.21 |
| Current liabilities | ||||
| Accounts payable | $59.58 | $72.74 | $60.36 | $48.98 |
| Deferred revenue | $11.78 | $13.63 | $13.91 | |
| Short long term debt | $9.01 | $7.79 | $6.97 | |
| Total current liabilities | $156.22 | $169.45 | $169.29 | $157.57 |
| Long term debt | $525.93 | $546.51 | $532.96 | $534.71 |
| Total noncurrent liabilities | $582.02 | $567.74 | $569.52 | |
| Total debt | $555.52 | $540.75 | $541.68 | |
| Total liabilities | $723.65 | $751.48 | $737.03 | $727.09 |
| Shareholders' equity | ||||
| Retained earnings | -$1247.75 | -$1208.14 | -$1167.46 | -$1118.96 |
| Other shareholder equity | -$8.41 | -$11.53 | -$10.79 | -$8.32 |
| Total shareholder equity | $17.11 | $37.55 | $78.12 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $220.97 | $84.7 | $187.25 | $107.77 |
| Short term investments | ||||
| Net receivables | $72.61 | $60.06 | $41.89 | $23.53 |
| Inventory | $136.84 | $101.52 | $91.7 | $46 |
| Total current assets | $451.09 | $255.63 | $331.16 | $184.16 |
| Long term investments | ||||
| Property, plant & equipment | $176.25 | $130.31 | $112.68 | $37.85 |
| Goodwill & intangible assets | $175.45 | $122.56 | $124.96 | $38.62 |
| Total noncurrent assets | $354.12 | $257.74 | $240.9 | $77.06 |
| Total investments | ||||
| Total assets | $805.21 | $513.38 | $572.05 | $261.22 |
| Current liabilities | ||||
| Accounts payable | $48.98 | $34.74 | $25.74 | $17.6 |
| Deferred revenue | $13.91 | $11.96 | ||
| Short long term debt | $6.97 | $19.79 | $4.55 | $5.08 |
| Total current liabilities | $157.57 | $138.87 | $101.09 | $58.31 |
| Long term debt | $534.71 | $349.51 | $350.87 | $38.08 |
| Total noncurrent liabilities | $569.52 | $411.22 | $391.54 | $73.03 |
| Total debt | $541.68 | $395.86 | $355.43 | $43.16 |
| Total liabilities | $727.09 | $526.49 | $492.63 | $131.34 |
| Shareholders' equity | ||||
| Retained earnings | -$1118.96 | -$934.47 | -$782.33 | -$638 |
| Other shareholder equity | -$8.32 | -$10.69 | -$5.99 | $1.2 |
| Total shareholder equity | $78.12 | -$36.71 | $79.42 | $129.88 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $150.72 | $145.57 | $138.48 | $137.97 |
| Cost of revenue | $42.98 | $41.13 | $42.78 | |
| Gross Profit | $102.73 | $102.59 | $97.35 | $95.19 |
| Operating activities | ||||
| Research & development | $19.11 | $18.01 | $22.28 | |
| Selling, general & administrative | $112.73 | $113.73 | $104.12 | |
| Total operating expenses | $133.41 | $137.75 | $140.57 | $140.02 |
| Operating income | -$35.15 | -$43.22 | -$44.83 | |
| Income from continuing operations | ||||
| EBIT | -$35.15 | -$43.22 | -$44.79 | |
| Income tax expense | -$0.04 | -$0.29 | -$0.07 | -$0.12 |
| Interest expense | -$6.57 | $5.82 | $5.34 | $4.42 |
| Net income | ||||
| Net income | -$39.62 | -$40.68 | -$48.49 | -$49.08 |
| Income (for common shares) | -$40.68 | -$48.49 | -$49.08 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $482.26 | $350.87 | $243.21 | $144.86 |
| Cost of revenue | $172.06 | $117.81 | $85.45 | $42.36 |
| Gross Profit | $310.2 | $233.06 | $157.76 | $102.5 |
| Operating activities | ||||
| Research & development | $70.11 | $44.03 | $32.02 | $18.75 |
| Selling, general & administrative | $374.08 | $300.01 | $229.27 | $129.16 |
| Total operating expenses | $483.6 | $380.03 | $285.82 | $161.36 |
| Operating income | -$173.4 | -$146.97 | -$128.06 | -$58.86 |
| Income from continuing operations | ||||
| EBIT | -$170.27 | -$146.5 | -$137.05 | -$66.47 |
| Income tax expense | -$0.28 | $0.14 | $0.16 | $0.14 |
| Interest expense | $16.64 | $5.5 | $7.11 | $12.37 |
| Net income | ||||
| Net income | -$186.64 | -$152.15 | -$144.33 | -$78.99 |
| Income (for common shares) | -$186.64 | -$152.15 | -$144.33 | -$78.99 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$40.68 | -$48.49 | -$49.08 | |
| Operating activities | ||||
| Depreciation | $21.07 | $18.92 | $16.96 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $16.96 | $17.32 | $20.52 | |
| Total cash flows from operations | -$11.39 | -$38.44 | -$25 | |
| Investing activities | ||||
| Capital expenditures | -$34.1 | -$31.31 | -$25.72 | |
| Investments | ||||
| Total cash flows from investing | -$89.39 | -$35.89 | -$33.62 | -$28.21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.33 | -$4.7 | $147.02 | |
| Net borrowings | $4.4 | $1.16 | $3.67 | |
| Total cash flows from financing | $5.57 | $3.24 | -$4.37 | $151.57 |
| Effect of exchange rate | -$1 | -$0.21 | -$0.46 | $0.09 |
| Change in cash and equivalents | -$139.99 | -$44.26 | -$76.89 | $98.44 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$186.64 | -$152.15 | -$144.33 | -$78.99 |
| Operating activities | ||||
| Depreciation | $59.68 | $43.93 | $30.17 | $11.63 |
| Business acquisitions & disposals | -$55 | -$83.23 | ||
| Stock-based compensation | $81.24 | $40.56 | $36.45 | $17.66 |
| Total cash flows from operations | -$78.48 | -$75.14 | -$73.43 | -$46.41 |
| Investing activities | ||||
| Capital expenditures | -$80.51 | -$49.45 | -$68.54 | -$23.1 |
| Investments | -$3 | |||
| Total cash flows from investing | -$141.97 | -$58.28 | -$157.76 | -$23.86 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $212.12 | -$3.04 | $100.86 | $111.04 |
| Net borrowings | $146.34 | $33.69 | $253.13 | $19.79 |
| Total cash flows from financing | $356.92 | $31.23 | $311.97 | $130.83 |
| Effect of exchange rate | -$0.18 | -$0.36 | -$1.29 | $0.09 |
| Change in cash and equivalents | $136.27 | -$102.55 | $79.48 | $60.65 |
News
Fundamentals
| Market cap | $2.88B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 143.91M |
| Revenue | $572.74M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$177.87M |
| Revenue Q/Q | 27.44% |
| Revenue Y/Y | 27.21% |
| P/E ratio | -16.19 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 5.03 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.56 |
| EPS | -$1.24 |
|---|---|
| ROA | -22.99% |
| ROE | N/A |
| Debt/Equity | 9.31 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.32 |
| Quick ratio | 1.15 |